Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Feb 5, 2019
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2019 PForm 4 → | Feb 4, 5:22 pm EST | AngioGenex, Inc.AGGX | Michael AronsteinDirector, 10% Owner | 1,000,000 | $0.20 | $200,000 | 3,500,000 | +40.0% | plan? late |
| Jan 15, 2019 PForm 4 → | Feb 5, 1:38 pm EST | Vystar CorpVYST | Bryan Lawrence StoneDirector | 1,439,381 | $0.0242 | $34,808 | 4,746,048 | +43.5% | plan? late |
| Feb 1, 2019 PForm 4 → | Feb 5, 3:55 pm EST | Acacia Diversified Holdings, Inc.ACCA | Neil B. GholsonDirector | 250,000 | $0.12 | $30,000 | 1,200,000 | +26.3% | plan? |
| Jan 31, 2019 PForm 4 → | Feb 4, 4:01 pm EST | PEN INC.PENC | Tom J. BermanPresident, Director | 47,120 | $0.40 | $18,848 | 47,120 | — | plan? |
| Jan 31, 2019 PForm 4 → | Feb 4, 4:23 pm EST | NOVAVAX INCNVAX | Gregory M GlennPresident, R&D | 13,168 | $0.88 | $11,588 | 73,386 | +21.9% | plan? |
| Jan 31, 2019 PForm 4 → | Feb 4, 4:53 pm EST | REXAHN PHARMACEUTICALS, INC.RNN | Charles BeeverDirector | 10,000 | $0.638 | $6,380 | 11,000 | +1,000% | plan? |
| Feb 1, 2019 PForm 4 → | Feb 5, 1:04 pm EST | Trinity Place Holdings Inc.TPHS | Matthew MessingerPresident and CEO, Director | 250 | $4.12 | $1,030 | 1,029,421 | +0.02% | plan? |
| Feb 4, 2019 PForm 4 → | Feb 5, 1:02 pm EST | Trinity Place Holdings Inc.TPHS | Steven KahnChief Financial Officer | 200 | $4.00 | $800 | 44,711 | +0.45% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.